Status:

COMPLETED

Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients

Lead Sponsor:

Pennington Biomedical Research Center

Conditions:

Diabetes

Hypoglycemia

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

A recent pilot study, GLIMPSE (NCT02690168), was recently completed which demonstrated that the rate of glial acetate metabolism (GAM) is closely associated with susceptibility to fasting-induced hypo...

Eligibility Criteria

Inclusion

  • Male or female
  • Ages 18-40 years
  • Diagnosed with type 1 diabetes with positive antibodies or dependent on insulin therapy
  • HbA1c of ≤8.5%
  • Modified Clarke's Hypoglycemia Questionnaire score of 12-24
  • Willing to participate in continuous glucose monitoring (CGM)

Exclusion

  • Contraindication to MRI
  • Consume \>10 alcoholic drinks/week
  • Current use of CGM
  • Current use of insulin pump
  • Current use of any diabetes medication other than insulin, e.g. SGLT1/2 inhibitors.
  • Current use of steroids, e.g. cortisone, and prednisone.
  • History of chronic smoking or have quit less than 10 years ago
  • History of cancer in the past 5 years (individuals with basal cell or squamous cell skin cancer would be allowed)
  • History of seizures
  • Significant, cardiac, vascular, pulmonary, gastrointestinal, neurologic, hematologic, rheumatologic, or psychiatric disease
  • Significant liver disease as defined as more than twice the upper limit of normal for liver enzymes
  • Significant renal disease as defined as a estimated glomerular filtration rate less than 30
  • Pregnant, planning to become pregnant, or breastfeeding
  • Have been hospitalized or treated in the past 3 months for severe hypoglycemia
  • Based on the investigative team's clinical judgement, a subject may not be appropriate for participation in the study.

Key Trial Info

Start Date :

August 19 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 4 2022

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT04430660

Start Date

August 19 2020

End Date

May 4 2022

Last Update

March 9 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States, 70808-4124

2

Tulane Medical Center

New Orleans, Louisiana, United States, 70112